NLS Global report

A new strategic collaboration between life science clusters from Northern Europe and the UK’s National Institute for Health and Care Research (NIHR) is set to open new pathways for companies to engage with the UK’s healthcare and research ecosystem.

With the agreement, the Novo Nordisk Foundation expands its existing collaboration with WHO, committing to a granting frame of up to DKK 380 million over the next four years.

The companies have entered into an agreement for the global co-development and co-commercialization of BioNTech’s investigational bispecific antibody BNT327 across numerous solid tumor types.

Opdivo is the first and only PD-1 inhibitor approved for subcutaneous (SC) use in the European Union.

The European Commission has launched the EU Startup and Scaleup Strategy, ‘Choose Europe to Start and Scale', to make Europe a great place to start and grow global technology-driven companies.

The decision by the 78th World Health Assembly culminates more than three years of intensive negotiations launched by governments in response to the devastating impacts of the COVID-19 pandemic.